Annual Current Liabilities
$15.04 M
-$2.30 M-13.29%
31 December 2023
Summary:
Trinity Biotech annual total current liabilities is currently $15.04 million, with the most recent change of -$2.30 million (-13.29%) on 31 December 2023. During the last 3 years, it has fallen by -$12.02 million (-44.43%). TRIB annual current liabilities is now -85.04% below its all-time high of $100.49 million, reached on 31 December 2021.TRIB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$28.05 M
+$2.28 M+8.86%
30 September 2024
Summary:
Trinity Biotech quarterly total current liabilities is currently $28.05 million, with the most recent change of +$2.28 million (+8.86%) on 30 September 2024. Over the past year, it has increased by +$15.32 million (+120.24%). TRIB quarterly current liabilities is now -73.44% below its all-time high of $105.62 million, reached on 30 June 2021.TRIB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -13.3% | +120.2% |
3 y3 years | -44.4% | -72.7% |
5 y5 years | -14.6% | +8.3% |
TRIB Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -85.0% | at low | -72.7% | +120.2% |
5 y | 5 years | -85.0% | at low | -73.4% | +120.2% |
alltime | all time | -85.0% | +784.4% | -73.4% | +1550.2% |
Trinity Biotech Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $28.05 M(+8.9%) |
June 2024 | - | $25.77 M(+12.9%) |
Mar 2024 | - | $22.82 M(+51.8%) |
Dec 2023 | $15.04 M(-13.3%) | $15.04 M(+18.0%) |
Sept 2023 | - | $12.74 M(-13.7%) |
June 2023 | - | $14.76 M(-8.6%) |
Mar 2023 | - | $16.15 M(-6.9%) |
Dec 2022 | $17.34 M(-82.7%) | $17.34 M(+17.7%) |
Sept 2022 | - | $14.73 M(+6.1%) |
June 2022 | - | $13.88 M(-12.9%) |
Mar 2022 | - | $15.94 M(-84.1%) |
Dec 2021 | $100.49 M(+271.4%) | $100.49 M(-2.3%) |
Sept 2021 | - | $102.88 M(-2.6%) |
June 2021 | - | $105.62 M(+233.8%) |
Mar 2021 | - | $31.65 M(+17.0%) |
Dec 2020 | $27.06 M(+39.1%) | $27.06 M(+17.2%) |
Sept 2020 | - | $23.10 M(+1.5%) |
June 2020 | - | $22.75 M(+3.1%) |
Mar 2020 | - | $22.06 M(+13.4%) |
Dec 2019 | $19.45 M(+10.5%) | $19.45 M(-24.9%) |
Sept 2019 | - | $25.90 M(+6.1%) |
June 2019 | - | $24.41 M(+23.2%) |
Mar 2019 | - | $19.81 M(+12.6%) |
Dec 2018 | $17.60 M(-17.1%) | $17.60 M(-15.6%) |
Sept 2018 | - | $20.87 M(+0.3%) |
June 2018 | - | $20.80 M(-6.1%) |
Mar 2018 | - | $22.16 M(+4.4%) |
Dec 2017 | $21.23 M(-16.0%) | $21.23 M(-9.7%) |
Sept 2017 | - | $23.50 M(+1.2%) |
June 2017 | - | $23.23 M(+9.8%) |
Mar 2017 | - | $21.15 M(-16.3%) |
Dec 2016 | $25.28 M(+25.5%) | $25.28 M(+21.4%) |
Sept 2016 | - | $20.82 M(+3.5%) |
June 2016 | - | $20.12 M(-0.9%) |
Mar 2016 | - | $20.30 M(+0.7%) |
Dec 2015 | $20.14 M(-8.7%) | $20.14 M(+2.2%) |
Sept 2015 | - | $19.72 M(-3.0%) |
June 2015 | - | $20.33 M(-1.6%) |
Mar 2015 | - | $20.66 M(-6.3%) |
Dec 2014 | $22.06 M(+5.2%) | $22.06 M(+39.8%) |
Sept 2014 | - | $15.78 M(-8.3%) |
June 2014 | - | $17.22 M(+2.8%) |
Mar 2014 | - | $16.75 M(-20.1%) |
Dec 2013 | $20.98 M(+61.8%) | $20.98 M(-8.7%) |
Sept 2013 | - | $22.98 M(+57.1%) |
June 2013 | - | $14.63 M(+2.5%) |
Mar 2013 | - | $14.27 M(+10.0%) |
Dec 2012 | $12.97 M(-2.7%) | $12.97 M(-6.8%) |
Sept 2012 | - | $13.91 M(+2.6%) |
June 2012 | - | $13.55 M(+12.0%) |
Mar 2012 | - | $12.10 M(-9.2%) |
Dec 2011 | $13.33 M(+8.8%) | $13.33 M(+7.3%) |
Sept 2011 | - | $12.43 M(-5.5%) |
June 2011 | - | $13.15 M(-4.7%) |
Mar 2011 | - | $13.79 M(+12.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $12.26 M(-52.1%) | $12.26 M(-9.9%) |
Sept 2010 | - | $13.60 M(+3.9%) |
June 2010 | - | $13.09 M(-49.1%) |
Mar 2010 | - | $25.70 M(+0.4%) |
Dec 2009 | $25.60 M(-28.3%) | $25.60 M(-17.9%) |
Sept 2009 | - | $31.18 M(-6.4%) |
June 2009 | - | $33.31 M(+2.1%) |
Mar 2009 | - | $32.63 M(-8.6%) |
Dec 2008 | $35.71 M(-17.9%) | $35.71 M(+3.3%) |
Sept 2008 | - | $34.55 M(+5.6%) |
June 2008 | - | $32.73 M(-23.2%) |
Mar 2008 | - | $42.59 M(-2.1%) |
Dec 2007 | $43.51 M(+21.1%) | $43.51 M(+29.9%) |
June 2007 | - | $33.49 M(-3.8%) |
Mar 2007 | - | $34.84 M(-3.1%) |
Dec 2006 | $35.94 M(+12.7%) | $35.94 M(-6.4%) |
Sept 2006 | - | $38.40 M(+11.4%) |
June 2006 | - | $34.46 M(+26.8%) |
Mar 2006 | - | $27.17 M(-14.8%) |
Dec 2005 | $31.90 M(+57.5%) | $31.90 M(+12.9%) |
Sept 2005 | - | $28.25 M(+32.9%) |
June 2005 | - | $21.26 M(+4.3%) |
Mar 2005 | - | $20.39 M(+0.6%) |
Dec 2004 | $20.26 M(+4.4%) | $20.26 M(+34.1%) |
Sept 2004 | - | $15.11 M(+5.4%) |
June 2004 | - | $14.33 M(-19.2%) |
Mar 2004 | - | $17.74 M(-8.6%) |
Dec 2003 | $19.40 M(+2.6%) | $19.40 M(+33.5%) |
Sept 2003 | - | $14.54 M(-11.1%) |
June 2003 | - | $16.35 M(-15.0%) |
Mar 2003 | - | $19.24 M(+1.7%) |
Dec 2002 | $18.91 M(+49.0%) | $18.91 M(+37.7%) |
Sept 2002 | - | $13.73 M(+16.1%) |
June 2002 | - | $11.84 M(-8.7%) |
Mar 2002 | - | $12.96 M(+2.1%) |
Dec 2001 | $12.69 M(+27.9%) | $12.69 M(+61.9%) |
Sept 2001 | - | $7.84 M(-14.6%) |
June 2001 | - | $9.18 M(-1.7%) |
Mar 2001 | - | $9.35 M(-5.8%) |
Dec 2000 | $9.92 M(-30.3%) | $9.92 M(+88.2%) |
Sept 2000 | - | $5.27 M(-32.5%) |
June 2000 | - | $7.81 M(-41.2%) |
Mar 2000 | - | $13.28 M(-6.7%) |
Dec 1999 | $14.23 M(-21.4%) | $14.23 M(-23.1%) |
Sept 1999 | - | $18.50 M(-5.6%) |
June 1999 | - | $19.60 M(+21.0%) |
Mar 1999 | - | $16.20 M(-10.5%) |
Dec 1998 | $18.10 M(+105.7%) | $18.10 M(+57.4%) |
Sept 1998 | - | $11.50 M(+30.7%) |
June 1998 | - | $8.80 M(0.0%) |
Dec 1997 | $8.80 M(+193.3%) | $8.80 M(+193.3%) |
Dec 1996 | $3.00 M(+76.5%) | $3.00 M(+76.5%) |
Dec 1995 | $1.70 M(-5.6%) | $1.70 M(0.0%) |
Dec 1994 | $1.80 M(+5.9%) | - |
Feb 1994 | - | $1.70 M |
Feb 1994 | $1.70 M | - |
FAQ
- What is Trinity Biotech annual total current liabilities?
- What is the all time high annual current liabilities for Trinity Biotech?
- What is Trinity Biotech annual current liabilities year-on-year change?
- What is Trinity Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Trinity Biotech?
- What is Trinity Biotech quarterly current liabilities year-on-year change?
What is Trinity Biotech annual total current liabilities?
The current annual current liabilities of TRIB is $15.04 M
What is the all time high annual current liabilities for Trinity Biotech?
Trinity Biotech all-time high annual total current liabilities is $100.49 M
What is Trinity Biotech annual current liabilities year-on-year change?
Over the past year, TRIB annual total current liabilities has changed by -$2.30 M (-13.29%)
What is Trinity Biotech quarterly total current liabilities?
The current quarterly current liabilities of TRIB is $28.05 M
What is the all time high quarterly current liabilities for Trinity Biotech?
Trinity Biotech all-time high quarterly total current liabilities is $105.62 M
What is Trinity Biotech quarterly current liabilities year-on-year change?
Over the past year, TRIB quarterly total current liabilities has changed by +$15.32 M (+120.24%)